{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Episode 437: Remembering David Mitchell","description":"    I don't have to remind anyone who listens to this podcast that the cost of MS disease-modifying therapies is obscenely high. And we're not just talking about relatively new medications. Older medications -- some decades old -- continue to increase in price without any rational explanation for why or how. &amp;nbsp; On January 2nd, we lost a true warrior in the ongoing battle to lower the price of prescription drugs when David Mitchell, the founder of Patients for Affordable Drugs, passed away. &amp;nbsp;      I met David in 2018 at a National MS Society Public Policy Conference, and he was a guest on Episode 31 of RealTalk MS. &amp;nbsp;This week, I'm re-sharing the conversation we had in 2018. We'll also tell you about an international workshop that represents the initial steps in developing a global research agenda to end MS. We're explaining how AI is about to have a major impact on healthcare. And we'll share the American Medical Association's brief to Congress, making the case for extending access to telehealth. We have a lot to talk about! Are you ready for RealTalk MS??!   This Week: We're remembering David Mitchell&amp;nbsp; :22 The first steps toward a global research agenda to prevent MS were just published&amp;nbsp; 1:02 Doctor AI will see you now&amp;nbsp; 5:45 The American Medical Association asks lawmakers to extend access to telehealth&amp;nbsp; 10:27 David Mitchell in his own words&amp;nbsp; 12:41 Share this episode&amp;nbsp; 27:56 Next week&amp;nbsp; 28:16   SHARE THIS EPISODE OF REALTALK MS Just copy this link &amp;amp; paste it into your text or email: https:\/\/realtalkms.com\/437 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is&amp;nbsp;your&amp;nbsp;opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the&amp;nbsp;RealTalk MS Listener Hotline&amp;nbsp;and share your thoughts! Email:&amp;nbsp;jon@realtalkms.com Phone:&amp;nbsp;(310) 526-2283 And don't forget to join us in the&amp;nbsp;RealTalk MS Facebook group!   LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the&amp;nbsp;RealTalk MS app&amp;nbsp;or at&amp;nbsp;www.RealTalkMS.com Patients for Affordable Drugs https:\/\/patientsforaffordabledrugs.org  PAPER: Toward a Global Research Agenda for Preventing Multiple Sclerosis https:\/\/journals.sagepub.com\/doi\/10.1177\/13524585251398381  AMA BRIEF: The Case for Permanent Telehealth Policy and Expanded Access to Virtual Care https:\/\/ama-assn.org\/system\/files\/issue-brief-telehealth-policy-expanded-access-to-virtual-care.pdf  ChatGPT Health https:\/\/openai.com\/index\/introducing-chatgpt-health  JOIN: The RealTalk MS Facebook Group https:\/\/facebook.com\/groups\/realtalkms REVIEW: Give RealTalk MS a rating and review http:\/\/www.realtalkms.com\/review   Follow RealTalk MS on Twitter,&amp;nbsp;@RealTalkMS_jon, and subscribe to our newsletter at our website,&amp;nbsp;RealTalkMS.com. RealTalk MS Episode 437 Guests: David Mitchell  Privacy Policy       ","author_name":"RealTalk MS","author_url":"http:\/\/www.realtalkms.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/39690200\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/197368815"}